ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 031,23
1,18%
Dow Jones
38 711,29
0,00%
DAX
18 614,21
1,07%
Brent Oil
77,79
0,88%
Bitcoin
71 043,94
0,59%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Relay Therapeutics Inc (RLAY)

  7. Relay Therapeutics Inc (RLAY) Actualités

RLAY Relay Therapeutics Inc

7,04
0,00 (0,00%)
Avant marché
Dernière mise à jour : 14:07:01
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Relay Therapeutics Inc RLAY NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 7,04 14:07:01
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
7,04
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
04/6/202422:07EDGAR2Form 144 - Report of proposed sale of securities
03/6/202422:05EDGAR2Form 8-K - Current report
21/5/202422:05GLOBERelay Therapeutics to Participate in Upcoming Investor..
13/5/202414:30GLOBERelay Therapeutics to Host New Program and Platform Event on..
02/5/202422:05GLOBERelay Therapeutics Reports First Quarter 2024 Financial..
25/4/202422:05GLOBERelay Therapeutics to Announce First Quarter 2024 Financial..
11/4/202422:05GLOBERelay Therapeutics to Participate in Upcoming Investor..
26/2/202422:05GLOBERelay Therapeutics to Participate in Three Upcoming Investor..
22/2/202422:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/2/202422:16EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202422:10EDGAR2Form 8-K - Current report
22/2/202422:05GLOBERelay Therapeutics Reports Fourth Quarter and Full Year 2023..
15/2/202422:05GLOBERelay Therapeutics to Announce Fourth Quarter and Full Year..
01/2/202422:05GLOBERelay Therapeutics to Participate in the Guggenheim..
31/1/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202415:22EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
10/1/202415:14EDGAR2Form D - Notice of Exempt Offering of Securities
08/1/202413:05EDGAR2Form 8-K - Current report
08/1/202413:00GLOBERelay Therapeutics Announces $30 Million Private Placement..
02/1/202422:05GLOBERelay Therapeutics to Present at 42nd Annual J.P. Morgan..
29/12/202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202322:16EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
07/11/202322:05GLOBERelay Therapeutics to Participate in Stifel 2023 Healthcare..
02/11/202321:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:10EDGAR2Form 8-K - Current report
02/11/202321:05GLOBERelay Therapeutics Reports Third Quarter 2023 Financial..
01/11/202321:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202321:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202322:05GLOBERelay Therapeutics to Announce Third Quarter 2023 Financial..
12/10/202322:13EDGAR2Form 8-K - Current report
12/10/202322:05GLOBERelay Therapeutics Announces Initial RLY-4008..
29/9/202323:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202322:05GLOBERelay Therapeutics to Present Clinical Data on RLY-4008 in..
08/8/202322:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:14EDGAR2Form 8-K - Current report
08/8/202322:02GLOBERelay Therapeutics Reports Second Quarter 2023 Financial..
01/8/202322:05GLOBERelay Therapeutics to Announce Second Quarter 2023 Financial..
31/7/202322:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202323:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
RLAY
Relay Therapeutics
EU
BNPKK
BNP Paribas Bnpp3.695%24...
BIT
P1KRQ0
NLBNPIT1KRQ0 20241220 23...
FX
CZKHKD
CZK vs HKD
LSE
SCO
Scotty Group
NASDAQ
XTXI
BIT
P1WEQ3
NLBNPIT1WEQ3 20240621 27
HITB
LOCUSD
LockTrip
USOTC
EXDW
Exceed World (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés